Dear Eric,
Did you had a chance to check the performance of CNVkit with pooled tumor samples? We have targeted, hybrid capture, sequencing data and have no normal samples. I'm wondering which of the following setups, in principal, should be preferred:
1) Calling CNVs with no control samples (a flat reference).
2) Calling CNVs with pool of tumor samples, that were prepared by the same library preparation method and sequenced together, which will use as a control.
I understand the advantage of using "panel of tumors", specially help to deal with the large variation of depth in the different targets and to reduce batch effects. However, the main drawback is that we will miss real CNAs since they appear in the tumor samples.
many thanks!